ENGLISH
中文 ENGLISH DEUTSCH
Client   IXING

POCT CLIA Analyzer LIA-12

TASK

IXING is a high-tech innovative IVD company focused on precise POCT technology platform and products. LIA-12 is the first Point-of-Care-Testing product based on homogeneous chemiluminescence principle in the world. Chemiluminescence immunoassay (CLIA) is a widely used detection method which combines the highly-sensitive chemiluminescence assay with highly-specific immune response and affinity of antibodies. Currently, CLIA is the latest developed and the most advanced immunoassay technology. The product design and user interface of LIA-12 was comissioned by IXING.

  • Definition of a recognizable IXING product language
  • Transfer to the design of the tabletop device

SERVICES

  • Ergonomic consideration
  • Industrial design
  • Product graphics
  • Colour Material Finishes
  • Graphical User interface

The entire visual elements of the brand, the product and
the user interface have been redesigned.

  • Primary

    Hex : # 985358

    R : 152 G : 83 B : 88

  • Primary

    Hex : # DB4F5C

    R : 219 G : 79 B : 92

  • Primary

    Hex : # EFE4D1

    R : 239 G : 228 B : 209

  • Secondary

    Hex : # EDECEA

    R : 237 G : 236 B : 234

  • Secondary

    Hex : # FFFFFF

    R : 255 G : 255 B : 255

The corporate design elements are reflected in the user
interface, which helps strengthen the brand.

BACK TO TOP

yimumu

Helped medical diagnostic instruments win the iF Design Award

yimumu

Helped medical diagnostic instruments win the iF Design Award

yimumu design & consulting GmbH

Dentenbergstrasse 76, 3076 Worb, Switzerland

  • Yi Salomo

    Legally represented by its Managing Director

  • Handelsregister Bern, CH-036.4.077.565-9

    Company Registration Number

  • yi.salomo@yimumu.com

    E-Mail

  • CHE-319.686.056

    UID/MWST in Switzerland